The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis
Open accessAbstract
Bacillus Calmette-Guérin (BCG) vaccine has failed to control the global tuberculosis (TB) epidemic, and there is a lack of safe and effective mucosal vaccines capable of potent protection against pulmonary TB. A recombinant replication-deficient adenoviral-based vaccine expressing an immunogenic Mycobacterium tuberculosis Ag Ag85A (AdAg85A) was engineered and evaluated for its potential to be used as a respiratory mucosal TB vaccine in a murine model of pulmonary TB. A single intranasal, but not i.m., immunization with AdAg85A provided potent protection against airway Mycobacterium tuberculosis challenge at an improved level over that by cutaneous BCG vaccination. Systemic priming with an Ag85A DNA vaccine and mucosal boosting with AdAg85A conferred a further enhanced immune protection which was remarkably better than BCG vaccination. Such superior protection triggered by AdAg85 mucosal immunization was correlated with much greater retention of Ag-specific T cells, particularly CD4 T cells, in the lung and was shown to be mediated by both CD4 and CD8 T cells. Thus, adenoviral TB vaccine represents a promising novel vaccine platform capable of potent mucosal immune protection against TB. Our study also lends strong evidence that respiratory mucosal vaccination is critically advantageous over systemic routes of vaccination against TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,947
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,542
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
How can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature Reviews Immunology · doi:10.1038/35095558 · Cited by 729
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
Self-citationVaccination against tuberculosis by DNA injection
Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., & Lowrie, D. B. (1996) · Nature Medicine · doi:10.1038/nm0896-888 · Cited by 506
Campbell, D. J., & Butcher, E. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011502 · Cited by 490
Therapy of tuberculosis in mice by DNA vaccination
Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., & Silva, C. L. (1999) · Nature · doi:10.1038/22326 · Cited by 474
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Vaccines against intracellular infections requiring cellular immunity
Seder, R. A., & Hill, A. V. S. (2000) · Nature · doi:10.1038/35021239 · Cited by 394
Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H., & Hill, A. V. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1602 · Cited by 360
Sambandamurthy, V. K., Wang, X., Chen, B., Russell, R. G., Derrick, S., Collins, F. M., Morris, S. L., & Jacobs, W. R. (2002) · Nature Medicine · doi:10.1038/nm765 · Cited by 336
Lötte, A., WASZ‐HÖCKERT, O., Poisson, N., Dumitrescu, N., Verron, M., & Couvet, E. (1984) · PubMed · Cited by 294
Hogan, R. J., Zhong, W., Usherwood, E. J., Cookenham, T., Roberts, A. D., & Woodland, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.981 · Cited by 288
Preventing Tuberculosis with Bacillus Calmette-Guérin Vaccine: A Meta-Analysis of the Literature
Brewer, T. F. (2000) · Clinical Infectious Diseases · doi:10.1086/314072 · Cited by 283
Brandtzaeg, P., Farstad, I. N., & Haraldsen, G. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01468-1 · Cited by 278
Gallichan, W. S., & Rosenthal, K. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1879 · Cited by 238
McShane, H., Brookes, R., Gilbert, S. C., & Hill, A. V. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.681-686.2001 · Cited by 231
Zganiacz, A., Santosuosso, M., Wang, J., Yang, T., Chen, L., Anzulovic, M., Alexander, S., Gicquel, B., Wan, Y., Bramson, J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18991 · Cited by 205
Self-citationLötte, A. (1984) · Medical Entomology and Zoology · Cited by 200
Tanghe, A., D'Souza, S., Rosseels, V., Denis, O., Ottenhoff, T. H. M., Dalemans, W., Wheeler, C., & Huygen, K. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.3041-3047.2001 · Cited by 184
Self-citationXu, B., Wagner, N., Pham, L. N., Magno, V., Shan, Z., Butcher, E. C., & Michie, S. A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20010685 · Cited by 177
Auxotrophic vaccines for tuberculosis
Guleria, I., Teitelbaum, R., McAdam, R. A., Kalpana, G., Jacobs, W. R., & Bloom, B. R. (1996) · Nature Medicine · doi:10.1038/nm0396-334 · Cited by 166
Addison, C., Hitt, M., Kunsken, D., & Graham, F. L. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-7-1653 · Cited by 166
Self-citationTB vaccines: progress and problems
Andersen, P. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01865-8 · Cited by 161
Li, Z., Howard, A., Kelley, C., Delogu, G., Collins, F., & Morris, S. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4780-4786.1999 · Cited by 160
Gallichan, W. S., & Rosenthal, K. L. (1998) · The Journal of Infectious Diseases · doi:10.1086/515286 · Cited by 133
Rodrigues, E. G., Zavala, F. P., Eichinger, D. J., Wilson, J. M., & Tsuji, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1268 · Cited by 122
Doherty, T. M., Olsen, A. W., van Pinxteren, L. A. H., & Andersen, P. L. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3111-3121.2002 · Cited by 95
Xing, Z., Ohkawara, Y., Jordana, M., Graham, F., & Gauldie, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300371 · Cited by 78
Self-citationIntranasal vaccination of mice against infection with Mycobacterium tuberculosis
Falero-Díaz, G., Challacombe, S., Banerjee, D., Douce, G. R., Boyd, A., & Iványi, J. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00134-1 · Cited by 69
Boyaka, P. N., McGhee, J. R., Czerkinsky, C. C., & Mestecky, J. F. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50051-6 · Cited by 68
DNA vaccines--challenges in delivery.
Pachuk, C., McCallus, D., WEINER, D. B., & Satishchandran, C. (2000) · PubMed · Cited by 56
Chambers, M. A., Williams, A., Gavier‐Widén, D., Whelan, A. O., Hall, G. A., Marsh, P. D., Bloom, B. R., Jacobs, W. R., & Hewinson, R. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7094-7099.2000 · Cited by 55
Palendira, U., Bean, A. G. D., Feng, C. G., & Britton, W. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.3.1410-1416.2002 · Cited by 51
Effectiveness of BCG vaccination against tuberculous meningitis.
Awasthi, S., & Moin, S. (1999) · PubMed · Cited by 40
Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation
Wang, J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00241-4 · Cited by 39
Self-citationTuberculosis vaccines: the past, present and future
Wang, J., & Xing, Z. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.3.341 · Cited by 34
Self-citationYoung, D. B., & Stewart, G. R. (2002) · British Medical Bulletin · doi:10.1093/bmb/62.1.73 · Cited by 24
Cited by
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
The success and failure of BCG — implications for a novel tuberculosis vaccine
Andersen, P., & Doherty, T. M. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1211 · Cited by 788
Zens, K. D., Chen, J. K., & Farber, D. L. (2016) · JCI Insight · doi:10.1172/jci.insight.85832 · Cited by 418
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
Sakai, S., Kauffman, K. D., Sallin, M. A., Sharpe, A. H., Young, H. A., Ganusov, V. V., & Barber, D. L. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005667 · Cited by 347
Metadata
- Authors
- Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., & Xing, Z.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11
- Volume
- 173
- Issue
- 10
- Pages
- 6357-6365
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1601917502
- Cited by
- 359
- References
- 41
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.